NanJing Pharmaceutical Company Limited

Shanghai Stock Exchange 600713.SS

NanJing Pharmaceutical Company Limited EBT Margin for the year ending December 31, 2023: 1.83%

NanJing Pharmaceutical Company Limited EBT Margin is 1.83% for the year ending December 31, 2023, a 1.17% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

NanJing Pharmaceutical Company Limited EBT Margin for the year ending December 31, 2022 was 1.80%, a -2.96% change year over year.
NanJing Pharmaceutical Company Limited EBT Margin for the year ending December 31, 2021 was 1.86%, a 9.21% change year over year.
NanJing Pharmaceutical Company Limited EBT Margin for the year ending December 31, 2020 was 1.70%, a 7.41% change year over year.
NanJing Pharmaceutical Company Limited EBT Margin for the year ending December 31, 2019 was 1.58%, a 4.27% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Shanghai Stock Exchange: 600713.SS

NanJing Pharmaceutical Company Limited

CEO	Mr. Liang Zhang
IPO Date	July 1, 1996
Location	China
Headquarters	Building A
Employees	4,903
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Retail & Wholesale

Description

NanJing Pharmaceutical Company Limited engages pharmaceutical wholesale and retail businesses in China. It also operates approximately 510 pharmacy retail stores and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Key trends

Past 5 years